In Petaluma, California, Axolabs operates a 90,000 sqft ISO8-qualified facility for cGMP production of oligonucleotides. A wide range of synthesizers and cleaning equipment enables the production of drug substance for technical, toxicological and preclinical to late clinical trials. The manufacturing is accompanied by laboratories for process/analysis development and cGMP quality control.